On September 7, 2021 Genocea Biosciences, Inc. (Nasdaq: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, reported that senior leadership plans to present at the following virtual conferences in September (Press release, Genocea Biosciences, SEP 7, 2021, View Source [SID1234587320]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Scientific conferences:

Event: Next Generation Cancer Vaccine Development Summit – Details
Topic: Neoantigen selection to identify immunogenic tumor specific targets personalized to each patient’s tumor and immune system
Format: Post Conference Workshop
Date: Thursday, September 9th
Time: 1:00 p.m. ET
Investor conferences:

Event: H.C. Wainwright 22nd Annual Global Investment Conference (virtual) – Details
Format: Presentation
Date: Monday, September 13th
Time: 7:00 a.m. ET

Event: Baird Global Healthcare Conference 2021 (virtual) – Details
Format: Presentation
Date: Wednesday, September 15th
Time: 11:25 a.m. ET